Extramedullary myeloma whole genome sequencing reveals novel mutations in Cereblon, proteasome subunit G2 and the glucocorticoid receptor in multi drug resistant disease

Jan B. Egan, K. Martin Kortuem, Ahmet Kurdoglu, Tyler Izatt, Jessica Aldrich, Rebecca Reiman, Lori Phillips, Angela Baker, Chang Xin Shi, Jessica Schmidt, Winnie S. Liang, David W. Craig, John D. Carpten, A. Keith Stewart

Research output: Contribution to journalLetter

32 Scopus citations
Original languageEnglish (US)
Pages (from-to)748-751
Number of pages4
JournalBritish journal of haematology
Volume161
Issue number5
DOIs
StatePublished - Jun 2013

Keywords

  • CRBN
  • Drug resistance
  • Myeloma
  • NR3C1
  • PSMG2

ASJC Scopus subject areas

  • Hematology

Cite this

Egan, J. B., Kortuem, K. M., Kurdoglu, A., Izatt, T., Aldrich, J., Reiman, R., Phillips, L., Baker, A., Shi, C. X., Schmidt, J., Liang, W. S., Craig, D. W., Carpten, J. D., & Stewart, A. K. (2013). Extramedullary myeloma whole genome sequencing reveals novel mutations in Cereblon, proteasome subunit G2 and the glucocorticoid receptor in multi drug resistant disease. British journal of haematology, 161(5), 748-751. https://doi.org/10.1111/bjh.12291